简体中文 | 繁體中文 | English

Press Releases

2020-02-24 09:27 Prohibition at Any Cost? Philip Morris International Hits Back at Global Campaign of Disinformation
2020-02-21 18:40 Kioxia First to Deliver PCIe® 4.0 Solid State Drives
2020-02-21 17:47 Movius Announces MultiLine for Salesforce on Salesforce AppExchange, the World's Leading Enterprise Cloud Marketplace
2020-02-21 16:40 EUV Photoresist Pioneer Inpria Raises $31 Million in Series C Funding Led by JSR Corporation
2020-02-21 15:23 Patents Must Not Block Coronavirus Treatment
2020-02-21 14:00 Meiji Seika Pharma Co., Ltd: Support for Control of Novel Coronavirus in China
2020-02-21 12:18 BrandShield Launches ElectionShield Product to Protect Political Campaigns From Online Threats
2020-02-21 10:38 Gigaphoton Unveils New Lasers for 2020
2020-02-20 17:48 EZconn Corporation Corrects PCT International’s Meritless Accusations
2020-02-20 17:13 Australian Government and Rimini Street Establish Whole-of-Government Agreement
2020-02-20 16:52 Galderma Announces New England Journal of Medicine Publication from Phase 2 Study of Investigational Therapy Nemolizumab in Patients with Moderate to Severe Prurigo Nodularis
2020-02-20 16:44 SES Responds to Intelsat’s Ex-parte Submission to the FCC Regarding the C-Band Spectrum Clearing Process
2020-02-20 15:58 The Taulia Working Capital Summit Jets Into Johannesburg, Alongside Partners Greensill and Intellection
2020-02-20 15:25 Lenovo Delivers Record Setting Q3 Performance With All Time Revenue And PTI Highs
2020-02-20 15:14 Sustainability Improvements Fail to Match Skyrocketing Air Travel Growth, According to OAG
2020-02-20 14:02 Rockwell Automation Strengthens Control & Visualization Portfolio with Acquisition of ASEM
2020-02-20 13:50 Northern Data and Canaan Inc Announce Cooperation on Blockchain-technology and AI
2020-02-20 13:34 Jinsan Beverage Leads Development of Beauty and Health Beverage Market with Its Brand ‘Jejuttre’
2020-02-20 10:22 Terns Pharmaceuticals Announces Safety and Pharmacodynamic Results of a Phase 1 Clinical Trial of TERN-101, a Liver-Selective FXR Agonist in Development for the Treatment of NASH
2020-02-20 10:03 Unitel Selects CSG to Drive Its Digital Transformation

Business Wire Weibo

Industries

Latest Releases